KUALA LUMPUR: Pharmaniaga Bhd
has the capacity to manufacture two million doses of COVID-19 vaccine developed by Sinovac Life Sciences Co Ltd per month beginning March this year.
Group managing director Datuk Zulkarnain Md Eusope said the vaccine would be the first to be manufactured in Malaysia at the small volume injectable high-tech plant owned by Pharmaniaga's wholly-owned subsidiary, Pharmaniaga LifeSciences Sdn Bhd, in Puchong.
Already a subscriber? Log in.
Save 30% for ads-free and full access now!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
